Final Stage 1 Rule Less Stringent And Positive (MDRX, QSII)

Enabling further progression in digitized health care, the Department of Health and Human Services (HHS) of the U.S. published the final rule for Stage 1 of achieving “meaningful use” of EHRs. This rule, which is less stringent than the Notice of Proposed Rule-making (NPRM), removed uncertainties for providers. While analysts at Jefferies and Company Inc., feel it to be positive for HCIT vendors like Allscripts-Misys Healthcare Solutions MDRX, Quality Systems, Inc. QSII and many more, they discard any possibility of incremented buying.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: AdvertisingConsumer DiscretionaryHealth CareHealth Care TechnologyInc.Information TechnologyJefferies and CompanySystems Software
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!